CGT9486-21-301 – PEAK Trial: A phase 3, randomised, open-label, multicentre clinical study of CGT9486+Sunitinib vs. Sunitinib in subjects with locally advanced, unresectable, or metastatic gastrointestinal stromal tumours
Chondragon: A randomised, blinded, placebo-controlled, phase 2 study of INBRX-109 in unresectable or metastatic conventional chondrosarcoma
EORTC QOL: Incorporating the patient voice in sarcoma research: How can we assess health-related quality of life in this heterogeneous group of patients
FaR-RMS: An overarching study for children and adults with frontline and relapsed rhabdomyosarcoma
ICONIC: Improving outcomes through collaboration in osteosarcoma
Inter-Ewings: International clinical research programme to improve outcomes in newly diagnosed Ewing sarcoma - Trial 1 (INTER-EWING-1)
ImmunoSARC2: Phase I-II trial of Sunitinib plus Nivolumab after standard treatment in advanced soft tissue and bone sarcomas
KINDRED ASSG: The International Sarcoma Kindred study: A global multi-site prospective cancer genetics study
Pharma Mar: Randomised, controlled, open-label, phase IIb/III study of Lurbinectedin in combination with Doxorubicin vs. Doxorubicin alone as a first-line treatment in patients with metastatic leiomyosarcoma.
PREDICT B: Predicting radiotherapy response, toxicities and quality of life related functional outcome in soft tissue sarcoma of the extremities: a prospective observational cohort study
rEECUr: International randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma
SPEARHEAD 1: A Phase II single arm open-label clinical trial of ADP-A2M4 SPEAR™ T cells in subjects with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Sometimes there may be other trials open - it is always worth asking your doctor.
